Meeder Asset Management Inc Sesen Bio, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.38 - $0.89 $6,926 - $16,222	-18,228 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$0.58 - $0.86 $10,572 - $15,676	18,228 New	18,228 $12,000
Q4 2021 Feb 11, 2022	SELL	$0.73 - $1.28 $10,068 - $17,653	-13,792 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$0.77 - $4.91 $9,882 - $63,014	12,834 Added 1339.67%	13,792 $11,000
Q2 2021 Aug 09, 2021	BUY	$2.18 - $4.66 $2,088 - $4,464	958 New	958 $4,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.